EUVIMEDEUVIMED entdecken
Crossref

FORMULATION AND PHARMACOLOGICAL EVALUATION OF POLYHERBAL FORMULATION FOR ANTIDIABETIC ACTIVITY BY USING STREPTOZOCIN INDUCED DIABETIC RATS

Shirish Upadhyay, Rupesh Soni

International Journal of Drug Delivery Technology · 06.07.2026 · 16 (62s)

DOI: 10.25258/ijddt.16.62s.83 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 06.07.2026. Verfasst von Shirish Upadhyay und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The main aim of the study is to design, optimization and pharmacological evaluation of polyherbal formulation for antidiabetic activity by using STZ induced diabetes. Methodology Four polyherbal formulations (A, B, C and D) were prepared by mixing specific plant extracts at documented therapeutic levels to enhance antidiabetic efficacy and bioavailability. The sustained release polymer matrix tablets were prepared by dry granulation using polyethylene oxide, xanthan gum, HPMC, sodium alginate and Kollidone SR as matrix components. Evaluation of thickness, friability, weight fluctuation and homogeneity of content. Acute oral toxicity studies were conducted in compliance with OECD Guideline 423. Antidiabetic activity was evaluated in Streptozotocin (STZ) induced diabetic Wistar rats. Animals were divided into four groups standard, diabetic, formulation treated and normal. Blood glucose levels were determined before and after the treatment and the formulation with the best glucose lowering action was selected. Result and Discussion All the plant extracts and polyherbal formulations were found to be safe and did not produce any behavioral abnormalities or mortality at dose level up to 2000 mg/kg. Individual extracts significantly reduced blood glucose levels in streptozotocin induced diabetic rats. Sustained-release matrix tablets prepared with different polymers showed good physicochemical characteristics and controlled drug release profiles. The formulations FA1 and FD1 at the dose of 200 mg/kg showed significant antidiabetic activity among the evaluated formulations. FD1 achieved the maximum reduction in blood glucose levels which was comparable with the conventional drug. Statistical analysis showed that the improved polyherbal formulation was effective and produced highly significant changes (p < 0.001) as compared with diabetic control animals.

Conclusion

The study showed that the polyherbal sustained-release preparations were safe and effective and could significantly reduce blood glucose levels in streptozotocin-induced diabetic rats. The regular drug and the studied formulations were compared and FD1 showed the best antidiabetic effect among them. The improved matrix tablet exhibited excellent safety, controlled drug release and satisfactory physicochemical characteristics up to 2000 mg/kg. The results suggest that polyherbal sustained release formulation is a promising therapeutic approach for successful treatment of diabetes mellitus.

Zitieren

APA

Upadhyay, S., & Soni, R. (2026). FORMULATION AND PHARMACOLOGICAL EVALUATION OF POLYHERBAL FORMULATION FOR ANTIDIABETIC ACTIVITY BY USING STREPTOZOCIN INDUCED DIABETIC RATS. International Journal of Drug Delivery Technology, 16(62s). https://doi.org/10.25258/ijddt.16.62s.83

Vancouver

Upadhyay S, Soni R. FORMULATION AND PHARMACOLOGICAL EVALUATION OF POLYHERBAL FORMULATION FOR ANTIDIABETIC ACTIVITY BY USING STREPTOZOCIN INDUCED DIABETIC RATS. International Journal of Drug Delivery Technology. 2026;16(62s). doi:10.25258/ijddt.16.62s.83

BibTeX
@article{Upadhyay2026,
  author = {Upadhyay, Shirish and Soni, Rupesh},
  title = {FORMULATION AND PHARMACOLOGICAL EVALUATION OF POLYHERBAL FORMULATION FOR ANTIDIABETIC ACTIVITY BY USING STREPTOZOCIN INDUCED DIABETIC RATS},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {62s},
  doi = {10.25258/ijddt.16.62s.83}
}
Kostenlos starten →